Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Teva Branded Pharm Drug Patent Portfolio

Teva Branded Pharm owns 16 orange book drugs protected by 95 US patents with Loestrin 24 Fe having the least patent protection, holding only 1 patent. And Austedo with maximum patent protection, holding 28 patents. Given below is the list of Teva Branded Pharm's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11266796 Inhalation device with integrated electronics 22 Feb, 2041
Active
US11173259 Drug delivery device with electronics and power management 06 Jul, 2040
Active
US11464923 Inhaler system 19 Jun, 2040
Active
US11439777 Drug delivery device with electronics 24 May, 2040
Active
US11344685 Drug delivery device with electronics 26 Sep, 2039
Active
US11000653 Inhaler 18 Dec, 2038
Active
US11357935 Drug delivery device with electronics 24 Sep, 2038
Active
US11179386 Analogs of deutetrabenazine, their preparation and use 15 Sep, 2038
Active
US11813232 Analogs of deutetrabenazine, their preparation and use 15 Sep, 2038
Active
US11179386 Analogs of deutetrabenazine, their preparation and use 15 Mar, 2038
Active
US11813232 Analogs of deutetrabenazine, their preparation and use 15 Mar, 2038
Active
US11351317 Drug delivery device with electronics 10 Feb, 2038
Active
US10959996 Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
Active
US11357772 Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
Active
US11446291 Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
Active
US11564917 Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
Active
US11648244 Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
Active
US12016858 Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
Active
US10569034 Compliance monitoring module for a breath-actuated inhaler 16 Aug, 2036
Active
US10959996 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
Active
US11357772 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
Active
US11446291 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
Active
US11564917 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
Active
US11648244 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
Active
US12016858 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
Active
US10918816 Compliance monitoring module for a breath-actuated inhaler 14 Dec, 2035
Active
US9782550 Compliance monitoring module for a breath-actuated inhaler 28 Aug, 2035
Active
US9782551 Compliance monitoring module for a breath-actuated inhaler 28 Aug, 2035
Active
US11666566 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
Active
US9233959 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
Active
US9296739 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
Active
US9550780 Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
Active
US9814708 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
Active
US11666566 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
Active
US9233959 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
Active
US9296739 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
Active
US9550780 Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
Active
US9814708 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
Active
US9327114 User-activated self-contained co-packaged iontophoretic drug delivery system 08 Oct, 2032
Active
US8978966 Dose counters for inhalers, inhalers and methods of assembly thereof 13 Jan, 2032
Active
US10561808 Dose counter for inhaler having an anti-reverse rotation actuator 01 Jan, 2032
Active
US10188811 Nasal spray device 21 Oct, 2031
Active
US8524733 Benzoquinoline inhibitors of vesicular monoamine transporter 2 03 Oct, 2031
Active
US9216260 Dose counters for inhalers, inhalers and methods of assembly thereof 28 Jun, 2031
Active
US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
Active
US10124131 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
Active
US9731087 Dose counter for inhaler having a bore and shaft arrangement 18 May, 2031
Active
US10022509 Dose counter for inhaler having a bore and shaft arrangement 18 May, 2031
Active
US10086156 Dose counter for inhaler and method for counting doses 18 May, 2031
Active
US10695512 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
Active
US11395889 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
Active
US9463289 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
Active
US9808587 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
Active
US8524733 Benzoquinoline inhibitors of vesicular monoamine transporter 2 03 Apr, 2031
Active
US8983594 Electronic control of drug delivery system 19 Nov, 2030
Active
US8445018 Abuse resistant drug formulation 31 Jul, 2029
Active
US8366600 Polyamine enhanced formulations for triptan compound iontophoresis 21 Apr, 2029
Active
US8415332 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens 11 Mar, 2029
Active
US7855190 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration 05 Dec, 2028
Active
US8132712 Metered-dose inhaler 07 Sep, 2028
Active
US8651103 Dry powder inhalation apparatus 26 Mar, 2028
Active
US9216176 Abuse resistant drug formulation 13 Sep, 2027
Active
US9572803 Abuse resistant drug formulation 13 Sep, 2027
Active
US9272137 Transdermal methods and systems for the delivery of anti-migraine compounds 07 Sep, 2027
Active
US7973058 Transdermal methods and systems for the delivery of anti-migraine compounds 12 Apr, 2027
Active
US8155737 Pharmacokinetics of iontophoretic sumatriptan administration 12 Apr, 2027
Active
US8470853 Transdermal methods and systems for the delivery of anti-migraine compounds 12 Apr, 2027
Active
US8597272 Pharmacokinetics of iontophoretic sumatriptan administration 12 Apr, 2027
Active
US9427578 Pharmacokinetics of iontophoretic sumatriptan administration 12 Apr, 2027
Active
US7780038 Dispensing apparatus with dosage counter 24 Jan, 2027
Active
US8450299 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens 07 Oct, 2025
Active
US10765820 Dry powder inhalation apparatus 19 May, 2025
Active
US9463288 Dry powder inhalation apparatus 19 May, 2025
Active
US7320969 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology 30 Jan, 2024 Expired
US7105152 Suspension aerosol formulations 12 Sep, 2023 Expired
US7858605 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology 23 Jun, 2023 Expired
US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology 15 Jun, 2023 Expired
US7540282 Reservoir pressure system for medicament inhaler 06 May, 2023 Expired
US6745071 Iontophoretic drug delivery system 21 Feb, 2023 Expired
US6701917 Dose counter for medicament inhaler 23 Jun, 2021 Expired
US6718972 Dose metering system for medicament inhaler 23 Jun, 2021 Expired
US6748947 De-agglomerator for breath-actuated dry powder inhaler 23 Jun, 2021 Expired
US6871646 De-agglomerator for breath-actuated dry powder inhaler 23 Jun, 2021 Expired
US8006690 Reservoir pressure system for medicament inhaler 23 Jun, 2021 Expired
US6156742 Emergency contraceptive kit 05 Dec, 2020 Expired
US6667050 Chewable oral contraceptive 06 Apr, 2019 Expired
US6446627 Inhaler dose counter 18 Dec, 2017 Expired
US5898032 Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy 23 Jun, 2017 Expired
USRE39861 Methods of extended use oral contraception 23 Jun, 2017 Expired
US7566445 Medicinal aerosols and methods of delivery thereof 04 Jun, 2017 Expired
US8834849 Medicinal aerosols and methods of delivery thereof 04 Jun, 2017 Expired
US5776432 Beclomethasone solution aerosol formulations 07 Jul, 2015 Expired
US5683677 Medicinal aerosol formulations 04 Nov, 2014 Expired
US5552394 Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy 22 Jul, 2014 Expired
US5605674 Medicinal aerosol formulations 25 Feb, 2014 Expired


Given below is the list of recent legal activities going on the following drug patents of Teva Branded Pharm.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 20 Jun, 2024 US9550780
Expire Patent
Critical
10 Jun, 2024 US9327114
Payment of Maintenance Fee, 8th Year, Large Entity 21 Mar, 2024 US9463288
Payment of Maintenance Fee, 8th Year, Large Entity 21 Mar, 2024 US9463288
Payment of Maintenance Fee, 8th Year, Large Entity 21 Mar, 2024 US9463289
Payment of Maintenance Fee, 4th Year, Large Entity 21 Feb, 2024 US10765820
Payment of Maintenance Fee, 4th Year, Large Entity 21 Feb, 2024 US10765820
Expire Patent
Critical
29 Jan, 2024 US9216176
Maintenance Fee Reminder Mailed
Critical
25 Dec, 2023 US9327114
Payment of Maintenance Fee, 4th Year, Large Entity 22 Nov, 2023 US10695512
Mail Patent eGrant Notification 14 Nov, 2023 US11813232
Recordation of Patent eGrant 14 Nov, 2023 US11813232
Patent eGrant Notification 14 Nov, 2023 US11813232
Email Notification
Critical
14 Nov, 2023 US11813232
Patent Issue Date Used in PTA Calculation
Critical
14 Nov, 2023 US11813232


Teva Branded Pharm's Drug Patent Litigations

Teva Branded Pharm's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Oct 26, 2018, against patent number US10561808. The petitioner , challenged the validity of this patent, with Declan Walsh et al. as the respondent. Click below to track the latest information on how companies are challenging Teva Branded Pharm's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8524733 September, 2021 Terminated-Denied
(09 Mar, 2022)
Auspex Pharmaceuticals, Inc. Apotex Inc.
US10561808 October, 2018 Decision
(20 Sep, 2019)
Declan Walsh et al.


Teva Branded Pharm Drug Patents' Oppositions Filed in EPO

Teva Branded Pharm drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Sep 03, 2009, by Vectura Delivery Devices Limited. This opposition was filed on patent number EP01948660A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP20172454A Nov, 2022 Vectura Limited Granted and Under Opposition
EP19155324A Jun, 2021 Vectura Limited Granted and Under Opposition
EP17811276A Mar, 2021 VECTURA DELIVERY DEVICES LIMITED Opposition rejected
EP17800844A Jun, 2020 Vectura Limited Opposition rejected
EP17800844A Feb, 2020 CHIESI FARMACEUTICI S.p.A. Opposition rejected
EP11779089A Jan, 2016 FRKelly Opposition rejected
EP01948660A Aug, 2014 Hexal Aktiengesellschaft Patent maintained as amended
EP02782404A Jun, 2014 Laboratorios Léon Farma, S.A. Revoked
EP02782404A Jun, 2014 Bröcher, Dirk Joachim Revoked
EP01948660A Sep, 2009 Vectura Delivery Devices Limited Patent maintained as amended


Teva Branded Pharm's Family Patents

Teva Branded Pharm drugs have patent protection in a total of 42 countries. It's US patent count contributes only to 22.5% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Teva Branded Pharm Drug List

Given below is the complete list of Teva Branded Pharm's drugs and the patents protecting them.


1. Austedo

Austedo is protected by 28 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11179386
(Pediatric)
Analogs of deutetrabenazine, their preparation and use 15 Sep, 2038
(13 years from now)
Active
US11813232
(Pediatric)
Analogs of deutetrabenazine, their preparation and use 15 Sep, 2038
(13 years from now)
Active
US11179386 Analogs of deutetrabenazine, their preparation and use 15 Mar, 2038
(12 years from now)
Active
US11813232 Analogs of deutetrabenazine, their preparation and use 15 Mar, 2038
(12 years from now)
Active
US10959996
(Pediatric)
Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
(11 years from now)
Active
US11357772
(Pediatric)
Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
(11 years from now)
Active
US11446291
(Pediatric)
Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
(11 years from now)
Active
US11564917
(Pediatric)
Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
(11 years from now)
Active
US11648244
(Pediatric)
Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
(11 years from now)
Active
US12016858
(Pediatric)
Methods for the treatment of abnormal involuntary movement disorders 07 Sep, 2036
(11 years from now)
Active
US10959996 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
(10 years from now)
Active
US11357772 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
(10 years from now)
Active
US11446291 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
(10 years from now)
Active
US11564917 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
(10 years from now)
Active
US11648244 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
(10 years from now)
Active
US12016858 Methods for the treatment of abnormal involuntary movement disorders 07 Mar, 2036
(10 years from now)
Active
US11666566
(Pediatric)
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
(8 years from now)
Active
US9233959
(Pediatric)
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
(8 years from now)
Active
US9296739
(Pediatric)
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
(8 years from now)
Active
US9550780
(Pediatric)
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
(8 years from now)
Active
US9814708
(Pediatric)
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Mar, 2034
(8 years from now)
Active
US11666566 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
(8 years from now)
Active
US9233959 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
(8 years from now)
Active
US9296739 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
(8 years from now)
Active
US9550780 Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
(8 years from now)
Active
US9814708 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 18 Sep, 2033
(8 years from now)
Active
US8524733
(Pediatric)
Benzoquinoline inhibitors of vesicular monoamine transporter 2 03 Oct, 2031
(6 years from now)
Active
US8524733 Benzoquinoline inhibitors of vesicular monoamine transporter 2 03 Apr, 2031
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Austedo's drug page


2. Loestrin 24 Fe

Loestrin 24 Fe is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5552394 Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy 22 Jul, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Loestrin 24 Fe's drug page


3. Loseasonique

Loseasonique is protected by 3 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7855190 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration 05 Dec, 2028
(3 years from now)
Active
US7858605 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology 23 Jun, 2023
(1 year, 10 months ago)
Expired
US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology 15 Jun, 2023
(1 year, 10 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Loseasonique's drug page


4. Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6667050 Chewable oral contraceptive 06 Apr, 2019
(6 years ago)
Expired
US5552394 Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy 22 Jul, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norethindrone And Ethinyl Estradiol And Ferrous Fumarate's drug page


5. Preven Emergency Contraceptive Kit

Preven Emergency Contraceptive Kit is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6156742 Emergency contraceptive kit 05 Dec, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Preven Emergency Contraceptive Kit's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Proair Digihaler

Proair Digihaler is protected by 27 patents, out of which 6 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11266796 Inhalation device with integrated electronics 22 Feb, 2041
(15 years from now)
Active
US11173259 Drug delivery device with electronics and power management 06 Jul, 2040
(15 years from now)
Active
US11464923 Inhaler system 19 Jun, 2040
(15 years from now)
Active
US11439777 Drug delivery device with electronics 24 May, 2040
(15 years from now)
Active
US11344685 Drug delivery device with electronics 26 Sep, 2039
(14 years from now)
Active
US11000653 Inhaler 18 Dec, 2038
(13 years from now)
Active
US11357935 Drug delivery device with electronics 24 Sep, 2038
(13 years from now)
Active
US11351317 Drug delivery device with electronics 10 Feb, 2038
(12 years from now)
Active
US10569034 Compliance monitoring module for a breath-actuated inhaler 16 Aug, 2036
(11 years from now)
Active
US10918816 Compliance monitoring module for a breath-actuated inhaler 14 Dec, 2035
(10 years from now)
Active
US9782550 Compliance monitoring module for a breath-actuated inhaler 28 Aug, 2035
(10 years from now)
Active
US9782551 Compliance monitoring module for a breath-actuated inhaler 28 Aug, 2035
(10 years from now)
Active
US8978966 Dose counters for inhalers, inhalers and methods of assembly thereof 13 Jan, 2032
(6 years from now)
Active
US10561808 Dose counter for inhaler having an anti-reverse rotation actuator 01 Jan, 2032
(6 years from now)
Active
US9216260 Dose counters for inhalers, inhalers and methods of assembly thereof 28 Jun, 2031
(6 years from now)
Active
US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
(6 years from now)
Active
US10124131 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US9731087 Dose counter for inhaler having a bore and shaft arrangement 18 May, 2031
(6 years from now)
Active
US8651103 Dry powder inhalation apparatus 26 Mar, 2028
(2 years from now)
Active
US10765820 Dry powder inhalation apparatus 19 May, 2025
(7 days from now)
Active
US9463288 Dry powder inhalation apparatus 19 May, 2025
(7 days from now)
Active
US7540282 Reservoir pressure system for medicament inhaler 06 May, 2023
(2 years ago)
Expired
US6701917 Dose counter for medicament inhaler 23 Jun, 2021
(3 years ago)
Expired
US6718972 Dose metering system for medicament inhaler 23 Jun, 2021
(3 years ago)
Expired
US6748947 De-agglomerator for breath-actuated dry powder inhaler 23 Jun, 2021
(3 years ago)
Expired
US6871646 De-agglomerator for breath-actuated dry powder inhaler 23 Jun, 2021
(3 years ago)
Expired
US8006690 Reservoir pressure system for medicament inhaler 23 Jun, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Proair Digihaler's drug page


7. Proair Hfa

Proair Hfa is protected by 14 patents, out of which 5 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10561808 Dose counter for inhaler having an anti-reverse rotation actuator 01 Jan, 2032
(6 years from now)
Active
US10022509 Dose counter for inhaler having a bore and shaft arrangement 18 May, 2031
(6 years from now)
Active
US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
(6 years from now)
Active
US10086156 Dose counter for inhaler and method for counting doses 18 May, 2031
(6 years from now)
Active
US10695512 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US11395889 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US9463289 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
(6 years from now)
Active
US9808587 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US8132712 Metered-dose inhaler 07 Sep, 2028
(3 years from now)
Active
US7105152 Suspension aerosol formulations 12 Sep, 2023
(1 year, 7 months ago)
Expired
US6446627 Inhaler dose counter 18 Dec, 2017
(7 years ago)
Expired
US7566445 Medicinal aerosols and methods of delivery thereof 04 Jun, 2017
(7 years ago)
Expired
US8834849 Medicinal aerosols and methods of delivery thereof 04 Jun, 2017
(7 years ago)
Expired
US5605674 Medicinal aerosol formulations 25 Feb, 2014
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Proair Hfa's drug page


8. Proair Respiclick

Proair Respiclick is protected by 18 patents, out of which 7 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9782550 Compliance monitoring module for a breath-actuated inhaler 28 Aug, 2035
(10 years from now)
Active
US9782551 Compliance monitoring module for a breath-actuated inhaler 28 Aug, 2035
(10 years from now)
Active
US8978966 Dose counters for inhalers, inhalers and methods of assembly thereof 13 Jan, 2032
(6 years from now)
Active
US10561808 Dose counter for inhaler having an anti-reverse rotation actuator 01 Jan, 2032
(6 years from now)
Active
US9216260 Dose counters for inhalers, inhalers and methods of assembly thereof 28 Jun, 2031
(6 years from now)
Active
US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
(6 years from now)
Active
US10124131 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US9731087 Dose counter for inhaler having a bore and shaft arrangement 18 May, 2031
(6 years from now)
Active
US8651103 Dry powder inhalation apparatus 26 Mar, 2028
(2 years from now)
Active
US10765820 Dry powder inhalation apparatus 19 May, 2025
(7 days from now)
Active
US9463288 Dry powder inhalation apparatus 19 May, 2025
(7 days from now)
Active
US7540282 Reservoir pressure system for medicament inhaler 06 May, 2023
(2 years ago)
Expired
US6701917 Dose counter for medicament inhaler 23 Jun, 2021
(3 years ago)
Expired
US6718972 Dose metering system for medicament inhaler 23 Jun, 2021
(3 years ago)
Expired
US6748947 De-agglomerator for breath-actuated dry powder inhaler 23 Jun, 2021
(3 years ago)
Expired
US6871646 De-agglomerator for breath-actuated dry powder inhaler 23 Jun, 2021
(3 years ago)
Expired
US8006690 Reservoir pressure system for medicament inhaler 23 Jun, 2021
(3 years ago)
Expired
US6446627 Inhaler dose counter 18 Dec, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Proair Respiclick's drug page


9. Qnasl

Qnasl is protected by 5 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10188811 Nasal spray device 21 Oct, 2031
(6 years from now)
Active
US7780038 Dispensing apparatus with dosage counter 24 Jan, 2027
(1 year, 8 months from now)
Active
US5776432 Beclomethasone solution aerosol formulations 07 Jul, 2015
(9 years ago)
Expired
US5683677 Medicinal aerosol formulations 04 Nov, 2014
(10 years ago)
Expired
US5605674 Medicinal aerosol formulations 25 Feb, 2014
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qnasl's drug page


10. Quartette

Quartette is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8415332 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens 11 Mar, 2029
(3 years from now)
Active
US8450299 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens 07 Oct, 2025
(4 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Quartette's drug page


11. Qvar 40

Qvar 40 is protected by 12 patents, out of which 4 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10561808 Dose counter for inhaler having an anti-reverse rotation actuator 01 Jan, 2032
(6 years from now)
Active
US10022509 Dose counter for inhaler having a bore and shaft arrangement 18 May, 2031
(6 years from now)
Active
US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
(6 years from now)
Active
US10086156 Dose counter for inhaler and method for counting doses 18 May, 2031
(6 years from now)
Active
US10695512 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US11395889 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US9463289 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
(6 years from now)
Active
US9808587 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US6446627 Inhaler dose counter 18 Dec, 2017
(7 years ago)
Expired
US5776432 Beclomethasone solution aerosol formulations 07 Jul, 2015
(9 years ago)
Expired
US5683677 Medicinal aerosol formulations 04 Nov, 2014
(10 years ago)
Expired
US5605674 Medicinal aerosol formulations 25 Feb, 2014
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qvar 40's drug page


12. Qvar 80

Qvar 80 is protected by 12 patents, out of which 4 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10561808 Dose counter for inhaler having an anti-reverse rotation actuator 01 Jan, 2032
(6 years from now)
Active
US10022509 Dose counter for inhaler having a bore and shaft arrangement 18 May, 2031
(6 years from now)
Active
US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
(6 years from now)
Active
US10086156 Dose counter for inhaler and method for counting doses 18 May, 2031
(6 years from now)
Active
US10695512 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US11395889 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US9463289 Dose counters for inhalers, inhalers and methods of assembly thereof 18 May, 2031
(6 years from now)
Active
US9808587 Dose counter for inhaler having an anti-reverse rotation actuator 18 May, 2031
(6 years from now)
Active
US6446627 Inhaler dose counter 18 Dec, 2017
(7 years ago)
Expired
US5776432 Beclomethasone solution aerosol formulations 07 Jul, 2015
(9 years ago)
Expired
US5683677 Medicinal aerosol formulations 04 Nov, 2014
(10 years ago)
Expired
US5605674 Medicinal aerosol formulations 25 Feb, 2014
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qvar 80's drug page


13. Seasonale

Seasonale is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5898032 Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy 23 Jun, 2017
(7 years ago)
Expired
USRE39861 Methods of extended use oral contraception 23 Jun, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Seasonale's drug page


14. Seasonique

Seasonique is protected by 4 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7855190 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration 05 Dec, 2028
(3 years from now)
Active
US7320969 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology 30 Jan, 2024
(1 year, 3 months ago)
Expired
US7858605 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology 23 Jun, 2023
(1 year, 10 months ago)
Expired
US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology 15 Jun, 2023
(1 year, 10 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Seasonique's drug page


15. Vantrela Er

Vantrela Er is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8445018 Abuse resistant drug formulation 31 Jul, 2029
(4 years from now)
Active
US9216176 Abuse resistant drug formulation 13 Sep, 2027
(2 years from now)
Active
US9572803 Abuse resistant drug formulation 13 Sep, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vantrela Er's drug page


16. Zecuity

Zecuity is protected by 10 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9327114 User-activated self-contained co-packaged iontophoretic drug delivery system 08 Oct, 2032
(7 years from now)
Active
US8983594 Electronic control of drug delivery system 19 Nov, 2030
(5 years from now)
Active
US8366600 Polyamine enhanced formulations for triptan compound iontophoresis 21 Apr, 2029
(3 years from now)
Active
US9272137 Transdermal methods and systems for the delivery of anti-migraine compounds 07 Sep, 2027
(2 years from now)
Active
US7973058 Transdermal methods and systems for the delivery of anti-migraine compounds 12 Apr, 2027
(1 year, 10 months from now)
Active
US8155737 Pharmacokinetics of iontophoretic sumatriptan administration 12 Apr, 2027
(1 year, 10 months from now)
Active
US8470853 Transdermal methods and systems for the delivery of anti-migraine compounds 12 Apr, 2027
(1 year, 10 months from now)
Active
US8597272 Pharmacokinetics of iontophoretic sumatriptan administration 12 Apr, 2027
(1 year, 10 months from now)
Active
US9427578 Pharmacokinetics of iontophoretic sumatriptan administration 12 Apr, 2027
(1 year, 10 months from now)
Active
US6745071 Iontophoretic drug delivery system 21 Feb, 2023
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zecuity's drug page